← Back to Search

Acupuncture Therapy for Anomia

N/A

Waitlist Available

Led By Janalee Stokken, MD

Research Sponsored by Mayo Clinic

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, post-treatment approximately 12 weeks

Awards & highlights

Study Summary

This trial is investigating if acupuncture can help improve the sense of smell in people who have had COVID-19.

Eligible Conditions

Anosmia
Coronavirus

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, post-treatment approximately 12 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, post-treatment approximately 12 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, post-treatment approximately 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in University of Pennsylvania Smell Identification Test (UPSIT) Scores

Secondary outcome measures

Change in Patient-reported Subjective Olfactory Loss

Change in Sino-Nasal Outcome Test (SNOT-22)

Side effects data

From 2022 Phase 2 trial • 45 Patients • NCT04496219

62%

Urinary Symptoms

58%

Fatigue

38%

Headache

35%

Hematuria

35%

Bowel Symptoms

35%

Flu-like Symptoms

31%

Other

27%

Pain

Bruise

100%

80%

60%

40%

20%

Study treatment Arm

Arm I (Acupuncture, BCG)

Arm II (BCG, Standard of Care)

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Acupuncture Therapy GroupExperimental Treatment3 Interventions

Subjects will undergo ten sessions of acupuncture therapy with a licensed acupuncturist in addition to the standard of care.

Group II: Standard of CareActive Control2 Interventions

Subjects will be treated with two times daily budesonide rinses and olfactory (sense of smell) training. This is considered the current standard of care in the treatment of olfactory dysfunction.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Acupuncture Therapy

2018

Completed Phase 2

~130

Budesonide

2017

Completed Phase 4

~13050

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor

3,207 Previous Clinical Trials

3,767,110 Total Patients Enrolled

Janalee Stokken, MDPrincipal InvestigatorMayo Clinic

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any available opportunities for enrolment in this research project?

"Affirmative. As per the information held on clinicaltrials.gov, this medical experiment is actively admitting patients; it was initially posted in December 2021 and recently updated in January 2022. The trial has to find 100 individuals from a single medical centre for participation."

Answered by AI

What is the participant capacity for this clinical research?

"Affirmative. The information found on clinicaltrials.gov indicates that this research endeavour, which was originally published on December 7th 2021, is actively recruiting individuals to join the trial. Approximately one hundred volunteers are needed from a single site of enrolment."

Answered by AI

What health conditions are typically addressed with Acupuncture Therapy?

"Acupuncture Therapy is commonly employed to treat acute coryza and can also be used in the treatment of proteinuria, nasal congestion, and Crohn's disease."

Answered by AI

Are there any other tests that have been done to assess the efficacy of Acupuncture Therapy?

"Currently, 32 medical studies on Acupuncture Therapy are in progress with 11 trials being conducted at Phase 3. A majority of the investigations take place in Xi'an, Shaanxi; however, there are almost a thousand clinical research sites for this therapeutic approach."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Acupuncture Therapy for COVID-Related Olfactory Loss

Janalee K. Stokken 2021. "Acupuncture Therapy for COVID-Related Olfactory Loss". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04952389.